Loading clinical trials...
Loading clinical trials...
Vaginal Microbiota Transplant to Promote Lactobacillus-dominant Cervicovaginal Communities
Conditions
Interventions
Vaginal microbiome transplant
Oral Metronidazole
+1 more
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
April 22, 2021
Primary Completion Date
September 30, 2026
Completion Date
September 30, 2026
Last Updated
July 18, 2025
Lead Sponsor
Douglas Kwon
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions